PROJECT TEAM
Jesper Bille, Overlæge, Aarhus University Hospital
Milos Fuglsang, Afdelingslæge, Aarhus University Hospital
THE NEED
Millions of patients rely on intranasal medication, but studies show that most use their nasal spray incorrectly—even after receiving instructions. This leads to poor treatment outcomes and avoidable side effects. With many nasal sprays sold over the counter, patients often receive no guidance at all.
THE SOLUTION
Rhinomate is a user-friendly add-on that fits any standard nasal spray bottle. Its built-in aiming guide helps users position the spray correctly, ensuring the medicine reaches the intended area and avoids the sensitive nasal septum. The design preserves the original spray function and requires no additional training.
Rhinomate - Aarhus University Hospital
Call 3 - 2022
500.000 DKK
Clinical Area
Otolaryngology
Technology
PROJECT SUMMARY
Rhinomate is a simple, attachable device designed to improve the accuracy of intranasal medicine administration. It ensures that nasal sprays are aimed correctly, increasing treatment effectiveness for patients with chronic rhinosinusitis, hay fever, and other nasal conditions.
CLINICAL IMPACT
Rhinomate improves disease control and reduces side effects, such as nosebleeds and septum perforation, leading to better quality of life for patients and fewer follow-up treatments. With chronic rhinosinusitis affecting 12% and hay fever 20–30% of Danish adults, the device has the potential to significantly ease the burden on both patients and the healthcare system.